M&A

In the Red? AstraZeneca Acquires FibroGen, Inc.’s China...

Pharma giant AstraZeneca announced plans to acquire FibroGen, Inc.’s China subsidiary for approximately $160...

Powering the Oil Boom: Atlas Energy to Acquire...

As President Trump promises to “unleash” oil and gas drilling, Atlas Energy has announced...

Bio Buyout: MaxCyte Acquires SeQure

Cell-engineering company, MaxCyte, Inc., announced it will acquire SeQure Dx, which focuses on editing...

Energy Boom: Kirkland and Wachtell Advise on $2.2...

As the Trump Administration opens the door to renewed hydrocarbon pipeline construction, energy giant...

Cars of the Future: NXP Semiconductors Acquires TTTech...

As car makers race toward new technologies, NXP Semiconductors N.V. announced plans to acquire...

Job Boom: Kirkland and Davis Polk Advise on...

As U.S. job growth shows unanticipated strength, payroll giant Paychex announced it plans to...

Q4 Roundup: Kirkland Leads Lackluster Rebound

While some analysts had forecasted 2024 as the “year for M&A Resurgence,” it wound...

Year in Review: 2024’s Blockbuster Deals 

Global M&A clawed its way back from the depths of 2023, as deal values...